Combination therapy containing ritonavir plus saquinavir has superior short-term antiretroviral efficacy: a randomized trialOle Kirk, Jens Lundgren, Terese L. Katzenstein et al.|AIDS|1999Cited by 84
Low efficacy and high frequency of adverse events in a randomized trial of the triple nucleoside regimen abacavir, stavudine and didanosineJan Gerstoft, Jens Lundgren, Ole Kirk et al.|AIDS|2003Cited by 80
Thymidine Analogue Mutation Profiles: Factors Associated with Acquiring Specific Profiles and their Impact on the Virological Response to TherapyAlessandro Cozzi‐Lepri, Panagiotis Gargalianos, Andrew Phillips et al.|Antiviral Therapy|2005Cited by 70
K65R with and without S68: A New Resistance Profile in Vivo Detected in Most Patients Failing Abacavir, Didanosine and StavudineBirgit Thorup Røge, Jan Gerstoft, Terese L. Katzenstein et al.|Antiviral Therapy|2003Cited by 68
Changes in use of antiretroviral therapy in regions of Europe over timeOle Kirk, Jens Lundgren, Amanda Mocroft et al.|AIDS|1998Cited by 64